Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer’s disease (from the Nakayama Study)

Alzheimer's disease (AD) is a progressive disease, and the number of AD patients is increasing every year as the population ages. One of the pathophysiological mechanisms of AD is thought to be the effect of metabolomic abnormalities. There have been several studies of metabolomic abnormalities...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozaki, Tomoki, Yoshino, Yuta, Tachibana, Ayumi, Shimizu, Hideaki, Mori, Takaaki, Nakayama, Tomohiko, Mawatari, Kazuaki, Numata, Shusuke, Iga, Jun-ichi, Takahashi, Akira, Ohmori, Tetsuro, Ueno, Shu-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458733/
https://www.ncbi.nlm.nih.gov/pubmed/36075959
http://dx.doi.org/10.1038/s41598-022-19670-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458733/
https://www.ncbi.nlm.nih.gov/pubmed/36075959
http://dx.doi.org/10.1038/s41598-022-19670-y

Ejemplares similares